2097262-58-1
Chemical Structure
TVB-3664
- CAS No.: 2097262-58-1
- Formula:C25H23F3N4O2
- Molecular Weight:468.47
IUPAC Name: 4-(1-(5-(4-(methoxymethyl)-2-(trifluoromethyl)-1H-imidazol-5-yl)-2,4-dimethylbenzoyl)azetidin-3-yl)benzonitrile
InChIKey: YFEOVRCUSPPGFZ-UHFFFAOYSA-N
SMILES: CC1=C(C=C(C(C)=C1)C(N2CC(C2)C3=CC=C(C=C3)C#N)=O)C4=C(N=C(N4)C(F)(F)F)COC
Biological Activity: TVB-3664 is an orally available, reversible, potent, selective and highly bioavailable fatty acid synthase (FASN) inhibitor, with IC50 values of 18 nM and 12 nM for human and mouse cell palmitate synthesis, respectively. TVB-3664 significantly reduces tubulin palmitoylation and mRNA expression[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TVB-3664 | 99.76% | TVB-3664 is an orally available, reversible, potent, selective and highly bioavailable fatty acid synthase (FASN) inhibitor, with IC50 values of 18 nM and 12 nM for human and mouse cell palmitate synthesis, respectively. TVB-3664 significantly reduces tubulin palmitoylation and mRNA expression. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.68
HY-U00436FASN-IN-3 -
Similarity Score 0.66
HY-120394TVB-3166 -
Similarity Score 0.54
HY-112829Denifanstat -
Similarity Score 0.46
HY-153730Hedgehog IN-5 -
Similarity Score 0.44
HY-159102PVP-037.2 -
Similarity Score 0.44
HY-147615CSF1R-IN-12 -
Similarity Score 0.44
HY-177291LAB687 -
Similarity Score 0.44
HY-18746KAI-407 -
Similarity Score 0.44
HY-19982AKT-IN-6 -
Explore the MedChemAI to find more analogs
References
- [1]. Zaytseva YY, et al. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer. Oncotarget. 2018 May 15;9(37):24787-24800. [Content Brief]
- [2]. Heuer TS, et al. FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression. EBioMedicine. 2017 Feb;16:51-62. [Content Brief]
